Stealth BioTherapeutics Corp. Sponsored ADR Debt to Equity Ratio 2019-2022 | MITO
Current and historical debt to equity ratio values for Stealth BioTherapeutics Corp. Sponsored ADR (MITO) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Stealth BioTherapeutics Corp. Sponsored ADR debt/equity for the three months ending March 31, 2022 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2022-03-31 | $0.09B | $-0.05B | -1.71 |
| 2021-12-31 | $0.10B | $-0.05B | -2.11 |
| 2021-09-30 | $0.07B | $-0.03B | -2.53 |
| 2021-06-30 | $0.06B | $-0.03B | -2.23 |
| 2021-03-31 | $0.05B | $-0.01B | -3.88 |
| 2020-12-31 | $0.05B | $-0.01B | -4.46 |
| 2020-09-30 | $0.02B | $0.00B | 8.91 |
| 2020-06-30 | $0.02B | $0.01B | 1.91 |
| 2020-03-31 | $0.03B | $0.00B | 12.25 |
| 2019-12-31 | $0.04B | $0.02B | 2.06 |
| 2019-09-30 | $0.04B | $0.00B | 9.71 |
| 2019-06-30 | $0.04B | $0.02B | 1.87 |
| 2019-03-31 | $0.04B | $0.03B | 1.15 |
| 2018-12-31 | $0.19B | $-0.18B | -1.09 |
| 2018-09-30 | $0.00B | 0.00 | |
| 2018-06-30 | $0.00B | 0.00 | |
| 2018-03-31 | $0.00B | 0.00 | |
